Intermittent Intravenous Levosimendan in Ambulatory Advanced Chronic Heart Failure Patients

NCT01536132 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Heart Failure

Interventions

DRUG: Levosimendan
DRUG: Placebo

Sponsor

Parc de Salut Mar